Skip to main content

Project ADMONT

IMMS has validated novel semiconductor process technology with passive RFID sensors and an in-vitro breast cancer diagnostic system.

The ADMONT project worked on extending CMOS process technologies with sensor components, among other things, to boost novel applications with innovative components and systems in the fields of mobility, energy, health and production. For this purpose, a distributed More-than-Moore (MtM) pilot line was set up by the consortium to prove that the new concepts can be produced with the various technologies. IMMS has used this framework to develop the following solutions, among others.

RFID chip supporting battery-free operation of off-the-shelf sensors for diagnostics and analytics.

The IMMS RFID chip supplies energy to individual commercial sensors with an I2C interface and transmits their measured data to an NFC-capable smartphone or other RFID readout device, contact-free. The integrated energy management system and I2C master enable energy-intensive measurements to be taken at low cost using NFC. The data is processed with an Android app.

Battery-less RFID sensor chip transmits measurement data from aqueous solutions.

The RFID sensor chip developed at IMMS allows NFC-enabled devices such as smartphones to retrieve temperature values, e.g. in cell culture monitoring applications. The challenge was to integrate RFID transponder and temperature sensor on a single chip and to achieve the working ranges and accuracies of commercially available stand-alone sensors. The chip is for use in extremely compact installation spaces.

Microelectronic contact imaging sensor for breast cancer in-vitro diagnostics.

To distinguish types and stages of breast cancer for targeted therapies, it has to date been necessary to initiate a slow, expensive further process of analysis in cases where the initial diagnosis is unclear. So that in future the exact disease classification will be completed in a single stage, IMMS‘ partners are currently investigating cell samples with an optoelectronic test system that IMMS has developed.

Acronym / Name:

ADMONT / Advanced Distributed Pilot Line for More-than-Moore Technologies

Duration:2015 – 2019

Project website:www.admont-project.eu

Application:

Automation technology and Industry 4.0|Life Sciences|Smart Health| Biosensors| In vitro diagnossis| Multi-parameter sensor networks| Biotechnology

Research field:Integrated sensor systems


Related content

All publicationsADMONT

Event,

Think Wireless IoT Day

Think Wireless IoT Day on Healthcare and Security

Event,

MEDICA 2019

Thüringen joint booth, hall 15 / 15L29

Event,

SMACD + PRIME 2019

5 lectures at the International Conference on Synthesis, Modeling, Analysis and Simulation Methods and Applications to Circuit Design and one lecture at the 15th Conference on PhD Research in Microelectronics and Electronics

Event,

BioCHIP 2019

BioCHIP Berlin International Forum on Biochips and Biochip Solutions

Press release,

Forschung und Entwicklung des IMMS für die Bioanalytik auf der MEDICA 2019

IMMS bietet Partnern für ihre Life-Science-Anwendungen F&E zu elektronischen Komponenten und Systemen

Press release,

Batteryless RFID sensor chip sends measured data out of aqueous solutions

IMMS demonstrates prototype at MEDICA, Nov 13th – 16th, Hall 3/G60

Press release,

IMMS presents three developments at MEDICA 2017

Nov 13th – Nov 16th 2017, Düsseldorf (Germany), joint booth DiagnostikNet BB, hall 3/G60


Contact

Contact

Eric Schäfer, M. Sc.

Head of Microelectronics / Branch Office Erfurt

eric.schaefer(at)imms.de+49 (0) 361 663 25 35

Eric Schäfer and his team research Integrated sensor systems, especially CMOS-based biosensors, ULP sensor systems and AI-based design and test automation. The results are being incorporated into research on the lead applications Sensor systems for in-vitro diagnostics and RFID sensor technology. It will assist you with services for the development of Integrated circuits and with IC design methods.


Funding

The ADMONT project has received funding from the ECSEL Joint Undertaking under grant agreement No 661796. This Joint Undertaking has received support as Innovation Action from the European Union's Horizon 2020 research and innovation programme, the German Federal Ministry of Education and Research (BMBF) and Finland, Sweden, Italy, Austria, Hungary. The IMMS sub-project ”Design of intelligent in vitro diagnostic und bioanalytical sensor and actuator systems“ has received funding under the reference 16ESE0057.


This might also be interesting for you

Core topic

CMOS-based biosensors

We are researching CMOS-integrated transducers and their interaction with biological receptors. They offer the potential for precise, digital and cost-effective point-of-care tests and allow properties to be recorded on a molecular scale.

Lead application

RFID sensor technology

We are researching energy-efficient solutions for RFID sensor technology in order to open up new applications and, for example, to make processes in industry more resource-efficient.

Lead application

Sensor systems for in-vitro diagnostics

Here we are developing sensor systems for in-vitro diagnostics that enable individual, decentralised health monitoring for all with electronic rapid tests.

Core topic

ULP sensor systems

We research and develop ultra-low-power (ULP) sensor systems that require very little power and have integrated energy management components. Our goal is to use them to open up new applications for the Internet of Things.

Back